Phage combination therapy can precisely target IBD-related gut bacteria without harming helpful microbes

E. coli engineered from stool samples can survive the hostile gut environment long enough to treat disease

Potential target for treatment among patients with type 2 diabetes

Bacteria busting proteins offer potential for smarter drugs